BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maes M, Barbosa DS, Almulla AF, Kanchanatawan B. A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine. Antioxidants 2022;11:803. [DOI: 10.3390/antiox11050803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Maes M, Brinholi FF, Michelin AP, Matsumoto AK, Semeão LDO, Almulla AF, Supasitthumrong T, Tunvirachaisakul C, Barbosa DS. Increased lipid peroxidation and lowered lipid-associated antioxidant defenses mediate the effects of the paraoxonase 1 (PON1) Q192R polymorphism on disabilities and final stroke core volume in mild and moderate stroke.. [DOI: 10.1101/2022.09.19.22280134] [Reference Citation Analysis]
2 Junior WLDT, Danelli T, Tano ZN, Cassela PLCS, Trigo GL, Cardoso KM, Loni LP, Ahrens TM, Espinosa BR, de Almeida ER, Lozovoy MAB, Reiche EM, Maes M, Simão C. Precision Medicine and Machine Learning to predict critical disease and death due to Coronavirus Disease 2019 (COVID-19).. [DOI: 10.21203/rs.3.rs-1946357/v1] [Reference Citation Analysis]
3 Maes M, Moraes JB, Congio A, Vargas HO, Nunes SOV. Research and Diagnostic Algorithmic Rules (RADAR) for mood disorders, recurrence of illness, suicidal behaviors, and the patient’s lifetime trajectory.. [DOI: 10.1101/2022.09.15.22279968] [Reference Citation Analysis]
4 Brinholi FF, Michelin AP, Matsumoto AK, Semeão LDO, Almulla AF, Supasitthumrong T, Tunvirachaisakul C, Barbosa DS, Maes M. Paraoxonase 1 status is a major Janus-faced component of mild and moderate acute ischemic stroke and consequent disabilities.. [DOI: 10.21203/rs.3.rs-1979784/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Brinholi FF, Michelin AP, Matsumoto AK, Semeão LDO, Almulla AF, Supasitthumrong T, Tunvirachaisakul C, Barbosa DS, Maes M. Paraoxonase 1 status is a major Janus-faced component of mild and moderate acute ischemic stroke and consequent disabilities.. [DOI: 10.1101/2022.08.12.22278728] [Reference Citation Analysis]